Hyderabad: The Drugs Controller General of India (DGCI) has given permission to Bharat Biotech to test its COVID-19 vaccine, COVAXIN, by administering it via the skin.
This intradermal vaccine delivery route is less invasive and will require a lesser dosage as well. The inactive virus-based vaccine is also being tested to be delivered in the intramuscular way.
Currently, the indigenously built vaccine is in phase II trials.
Bhubaneswar: The Odisha Vigilance sleuths on Sunday apprehended Assistant Agriculture Officer lock Technology Manager and… Read More
New Delhi: In a revealing account, Elon Musk has shed light on the dramatic circumstances… Read More
Kolkata: With emotions running high well before Indian and Pakistan clash for Champions Trophy in… Read More
Bhubaneswar: The India Meteorological Department (IMD) has issued nowcast warning for six districts of Odisha… Read More
Bhubaneswar: Excitement is reaching fever pitch as millions of fans from India and Pakistan tune… Read More
New Delhi: In the 119th episode of his monthly radio program "Mann Ki Baat," broadcast… Read More
This website uses cookies.
